Stay updated on Study Coagulation Factor VIIa in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Study Coagulation Factor VIIa in Hemophilia Clinical Trial page.

Latest updates to the Study Coagulation Factor VIIa in Hemophilia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record describes a Phase 3 study of MarzAA for bleeding episodes in people with hemophilia A or B with inhibitors. It includes the study’s terminated status, eligibility criteria, treatment comparison, locations, and outcome measure.SummaryDifference50%

- Check18 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the 403 error message for the study page.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the study page remains an access-denied error screen.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now returns a 403 Forbidden error instead of displaying the study record. The detailed study content and navigation elements are removed or hidden, leaving only the error message and standard footer.SummaryDifference15%

Stay in the know with updates to Study Coagulation Factor VIIa in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study Coagulation Factor VIIa in Hemophilia Clinical Trial page.